{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:27:55Z","timestamp":1774592875786,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00428-020-02759-y","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T22:59:35Z","timestamp":1580252375000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Immune checkpoint status and tumor microenvironment in vulvar squamous cell carcinoma"],"prefix":"10.1007","volume":"477","author":[{"given":"Margaret","family":"Cocks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alcides","family":"Chaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik G.","family":"Jenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Del Carmen","family":"Rodriguez Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline C.","family":"Tregnago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Lisa","family":"Eich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-9134","authenticated-orcid":false,"given":"George J.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"2759_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ogc.2012.04.002","volume":"39","author":"JS Carter","year":"2012","unstructured":"Carter JS, Downs LS (2012) Vulvar and vaginal cancer. Obstet Gynecol Clin N Am 39:213\u2013231. https:\/\/doi.org\/10.1016\/j.ogc.2012.04.002","journal-title":"Obstet Gynecol Clin N Am"},{"key":"2759_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/PAS.0000000000000454","volume":"39","author":"F Dong","year":"2015","unstructured":"Dong F, Kojiro S, Borger DR, Growdon WB, Oliva E (2015) Squamous cell carcinoma of the vulva: a subclassification of 97 cases by clinicopathologic, immunohistochemical, and molecular features (p16, p53, and EGFR). Am J Surg Pathol 39:1045\u20131053. https:\/\/doi.org\/10.1097\/PAS.0000000000000454","journal-title":"Am J Surg Pathol"},{"key":"2759_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/PGP.0000000000000280","volume":"35","author":"SM Bigby","year":"2016","unstructured":"Bigby SM, Eva LJ, Fong KL, Jones RW (2016) The natural history of vulvar intraepithelial neoplasia, differentiated type: evidence for progression and diagnostic challenges. Int J Gynecol Pathol 35:574\u2013584. https:\/\/doi.org\/10.1097\/PGP.0000000000000280","journal-title":"Int J Gynecol Pathol"},{"key":"2759_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.bpobgyn.2015.01.004","volume":"29","author":"NF Hacker","year":"2015","unstructured":"Hacker NF, Barlow EL (2015) Staging for vulvar cancer. Best Pract Res Clin Obstet Gynaecol 29:802\u2013811. https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.01.004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2759_CR5","doi-asserted-by":"publisher","unstructured":"FIGO Committee on Gynecologic Oncology (2014) FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int J Gynaecol Obstet 125:97\u201398. https:\/\/doi.org\/10.1016\/j.ijgo.2014.02.003","DOI":"10.1016\/j.ijgo.2014.02.003"},{"key":"2759_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.6004\/jnccn.2016.0184","volume":"14","author":"BE Greer","year":"2016","unstructured":"Greer BE, Koh W-J (2016) New NCCN guidelines for vulvar cancer. J Natl Compr Cancer Netw 14:656\u2013658. https:\/\/doi.org\/10.6004\/jnccn.2016.0184","journal-title":"J Natl Compr Cancer Netw"},{"key":"2759_CR7","doi-asserted-by":"publisher","unstructured":"Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS (1990) Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38:309\u2013314. https:\/\/doi.org\/10.1016\/0090-8258(90)90064-r","DOI":"10.1016\/0090-8258"},{"key":"2759_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1006\/gyno.1994.1087","volume":"53","author":"R Farias-Eisner","year":"1994","unstructured":"Farias-Eisner R, Cirisano FD, Grouse D, Leuchter RS, Karlan BY, Lagasse LD, Berek JS (1994) Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol 53:55\u201358. https:\/\/doi.org\/10.1006\/gyno.1994.1087","journal-title":"Gynecol Oncol"},{"key":"2759_CR9","first-page":"155","volume":"63","author":"NF Hacker","year":"1984","unstructured":"Hacker NF, Berek JS, Lagasse LD et al (1984) Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 63:155\u2013162","journal-title":"Obstet Gynecol"},{"key":"2759_CR10","first-page":"86","volume":"37","author":"ME C\u0103p\u00eelna","year":"2016","unstructured":"C\u0103p\u00eelna ME, Szabo B, Nicolau CR, Daniilidis A, Neagoe RM, Moldovan B (2016) The mandatory role of groin lymphadenectomy in clinical stages IB and II vulvar cancer. Eur J Gynaecol Oncol 37:86\u201388","journal-title":"Eur J Gynaecol Oncol"},{"key":"2759_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.gore.2017.02.004","volume":"20","author":"A Kaban","year":"2017","unstructured":"Kaban A, Kaban I, Af\u015far S (2017) Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement. Gynecol Oncol Rep 20:41\u201346. https:\/\/doi.org\/10.1016\/j.gore.2017.02.004","journal-title":"Gynecol Oncol Rep"},{"key":"2759_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/pon.3992","volume":"25","author":"GL Jones","year":"2016","unstructured":"Jones GL, Jacques RM, Thompson J, Wood HJ, Hughes J, Ledger W, Alazzam M, Radley SC, Tidy JA (2016) The impact of surgery for vulval cancer upon health-related quality of life and pelvic floor outcomes during the first year of treatment: a longitudinal, mixed methods study. Psychooncology 25:656\u2013662. https:\/\/doi.org\/10.1002\/pon.3992","journal-title":"Psychooncology"},{"key":"2759_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1046\/j.1525-1438.2003.13304.x","volume":"13","author":"KN Gaarenstroom","year":"2003","unstructured":"Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AA, Vergote I (2003) Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 13:522\u2013527. https:\/\/doi.org\/10.1046\/j.1525-1438.2003.13304.x","journal-title":"Int J Gynecol Cancer"},{"key":"2759_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2298\/MPNS1204097P","volume":"65","author":"M Pantelic","year":"2012","unstructured":"Pantelic M, Durdevi\u0107 S, Nikoli\u0107 D, Maksimovi\u0107 M (2012) Surgical treatment of invasive vulvar cancer. Med Pregl 65:97\u2013101","journal-title":"Med Pregl"},{"key":"2759_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/1471-0528.14560","volume":"124","author":"J Yap","year":"2017","unstructured":"Yap J, O\u2019Neill D, Nagenthiran S et al (2017) Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva. BJOG 124:946\u2013954. https:\/\/doi.org\/10.1111\/1471-0528.14560","journal-title":"BJOG"},{"key":"2759_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1521-6934(03)00050-6","volume":"17","author":"J Coulter","year":"2003","unstructured":"Coulter J, Gleeson N (2003) Local and regional recurrence of vulval cancer: management dilemmas. Best Pract Res Clin Obstet Gynaecol 17:663\u2013681","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2759_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40169-016-0130-5","volume":"6","author":"G D\u2019Errico","year":"2017","unstructured":"D\u2019Errico G, Machado HL, Sainz B (2017) A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet. Clin Transl Med 6:3. https:\/\/doi.org\/10.1186\/s40169-016-0130-5","journal-title":"Clin Transl Med"},{"key":"2759_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.urolonc.2017.09.023","volume":"35","author":"DM Gill","year":"2017","unstructured":"Gill DM, Agarwal N (2017) Cancer immunotherapy: a paradigm shift in the treatment of advanced urologic cancers. Urol Oncol 35:676\u2013677. https:\/\/doi.org\/10.1016\/j.urolonc.2017.09.023","journal-title":"Urol Oncol"},{"key":"2759_CR19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/0008-5472.CAN-17-0491","volume":"78","author":"A Taylor","year":"2018","unstructured":"Taylor A, Rothstein D, Rudd CE (2018) Small-molecule inhibition of PD-1 transcription is an effective alternative to antibody blockade in cancer therapy. Cancer Res 78:706\u2013717. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0491","journal-title":"Cancer Res"},{"key":"2759_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793\u2013800. https:\/\/doi.org\/10.1038\/nm730","journal-title":"Nat Med"},{"key":"2759_CR21","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1200\/JCO.2017.72.5952","volume":"35","author":"PA Ott","year":"2017","unstructured":"Ott PA, Bang Y-J, Berton-Rigaud D, Elez E, Pishvaian MJ, Rugo HS, Puzanov I, Mehnert JM, Aung KL, Lopez J, Carrigan M, Saraf S, Chen M, Soria JC (2017) Safety and antitumor activity of pembrolizumab in advanced programmed death ligand 1-positive endometrial cancer: results from the KEYNOTE-028 study. J Clin Oncol 35:2535\u20132541. https:\/\/doi.org\/10.1200\/JCO.2017.72.5952","journal-title":"J Clin Oncol"},{"key":"2759_CR22","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e20","volume":"28","author":"V Heong","year":"2017","unstructured":"Heong V, Ngoi N, Tan DSP (2017) Update on immune checkpoint inhibitors in gynecological cancers. J Gynecol Oncol 28:e20. https:\/\/doi.org\/10.3802\/jgo.2017.28.e20","journal-title":"J Gynecol Oncol"},{"key":"2759_CR23","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/lary.26629","volume":"127","author":"MA Blasco","year":"2017","unstructured":"Blasco MA, Svider PF, Raza SN, Jacobs JR, Folbe AJ, Saraf P, Eloy JA, Baredes S, Fribley AM (2017) Systemic therapy for head and neck squamous cell carcinoma: historical perspectives and recent breakthroughs. Laryngoscope 127:2565\u20132569. https:\/\/doi.org\/10.1002\/lary.26629","journal-title":"Laryngoscope"},{"key":"2759_CR24","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/modpathol.2015.108","volume":"28","author":"L Mezache","year":"2015","unstructured":"Mezache L, Paniccia B, Nyinawabera A, Nuovo GJ (2015) Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers. Mod Pathol 28:1594\u20131602. https:\/\/doi.org\/10.1038\/modpathol.2015.108","journal-title":"Mod Pathol"},{"key":"2759_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/modpathol.2016.64","volume":"29","author":"AM Heeren","year":"2016","unstructured":"Heeren AM, Punt S, Bleeker MC, Gaarenstroom KN, van der Velden J, Kenter GG, de Gruijl TD, Jordanova ES (2016) Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix. Mod Pathol 29:753\u2013763. https:\/\/doi.org\/10.1038\/modpathol.2016.64","journal-title":"Mod Pathol"},{"key":"2759_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/jamaoncol.2015.6326","volume":"2","author":"BE Howitt","year":"2016","unstructured":"Howitt BE, Sun HH, Roemer MGM, Kelley A, Chapuy B, Aviki E, Pak C, Connelly C, Gjini E, Shi Y, Lee L, Viswanathan A, Horowitz N, Neuberg D, Crum CP, Lindeman NL, Kuo F, Ligon AH, Freeman GJ, Hodi FS, Shipp MA, Rodig SJ (2016) Genetic basis for PD-L1 expression in squamous cell carcinomas of the cervix and vulva. JAMA Oncol 2:518\u2013522. https:\/\/doi.org\/10.1001\/jamaoncol.2015.6326","journal-title":"JAMA Oncol"},{"key":"2759_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ygyno.2017.05.011","volume":"146","author":"ML Palisoul","year":"2017","unstructured":"Palisoul ML, Mullen MM, Feldman R, Thaker PH (2017) Identification of molecular targets in vulvar cancers. Gynecol Oncol 146:305\u2013313. https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.011","journal-title":"Gynecol Oncol"},{"key":"2759_CR28","doi-asserted-by":"publisher","first-page":"89903","DOI":"10.18632\/oncotarget.20911","volume":"8","author":"JJ Sznurkowski","year":"2017","unstructured":"Sznurkowski JJ, \u017bawrocki A, Sznurkowska K, P\u0119ksa R, Biernat W (2017) PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients. Oncotarget 8:89903\u201389912. https:\/\/doi.org\/10.18632\/oncotarget.20911","journal-title":"Oncotarget"},{"key":"2759_CR29","doi-asserted-by":"publisher","first-page":"92890","DOI":"10.18632\/oncotarget.21641","volume":"8","author":"T Hecking","year":"2017","unstructured":"Hecking T, Thiesler T, Schiller C, Lunkenheimer JM, Ayub TH, Rohr A, Condic M, Keyver-Paik MD, Fimmers R, Kirfel J, Kuhn W, Kristiansen G, K\u00fcbler K (2017) Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology. Oncotarget 8:92890\u201392903. https:\/\/doi.org\/10.18632\/oncotarget.21641","journal-title":"Oncotarget"},{"key":"2759_CR30","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","volume":"27","author":"AM Udager","year":"2016","unstructured":"Udager AM, Liu T-Y, Skala SL, Magers MJ, McDaniel A, Spratt DE, Feng FY, Siddiqui J, Cao X, Fields KL, Morgan TM, Palapattu GS, Weizer AZ, Chinnaiyan AM, Alva A, Montgomery JS, Tomlins SA, Jiang H, Mehra R (2016) Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann Oncol 27:1706\u20131712. https:\/\/doi.org\/10.1093\/annonc\/mdw216","journal-title":"Ann Oncol"},{"key":"2759_CR31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A (2014) PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515:568\u2013571. https:\/\/doi.org\/10.1038\/nature13954","journal-title":"Nature"},{"key":"2759_CR32","doi-asserted-by":"publisher","first-page":"39916","DOI":"10.18632\/oncotarget.9537","volume":"7","author":"R Pichler","year":"2016","unstructured":"Pichler R, Fritz J, Zavadil C, Sch\u00e4fer G, Culig Z, Brunner A (2016) Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Gu\u00e9rin therapy in bladder cancer. Oncotarget 7:39916\u201339930. https:\/\/doi.org\/10.18632\/oncotarget.9537","journal-title":"Oncotarget"},{"key":"2759_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00428-018-2364-7","volume":"473","author":"M Choschzick","year":"2018","unstructured":"Choschzick M, Gut A, Fink D (2018) PD-L1 receptor expression in vulvar carcinomas is HPV-independent. Virchows Arch 473:513\u2013516. https:\/\/doi.org\/10.1007\/s00428-018-2364-7","journal-title":"Virchows Arch"},{"key":"2759_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/MOO.0000000000000341","volume":"25","author":"L Jouhi","year":"2017","unstructured":"Jouhi L, Hagstr\u00f6m J, Atula T, M\u00e4kitie A (2017) Is p16 an adequate surrogate for human papillomavirus status determination? Curr Opin Otolaryngol Head Neck Surg 25:108\u2013112. https:\/\/doi.org\/10.1097\/MOO.0000000000000341","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"2759_CR35","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/modpathol.2011.91","volume":"24","author":"NF Schlecht","year":"2011","unstructured":"Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB (2011) A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol 24:1295\u20131305. https:\/\/doi.org\/10.1038\/modpathol.2011.91","journal-title":"Mod Pathol"},{"key":"2759_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/PGP.0000000000000263","volume":"35","author":"AS Cheng","year":"2016","unstructured":"Cheng AS, Karnezis AN, Jordan S, Singh N, McAlpine J, Gilks CB (2016) p16 Immunostaining allows for accurate subclassification of vulvar squamous cell carcinoma into HPV-associated and HPV-independent cases. Int J Gynecol Pathol 35:385\u2013393. https:\/\/doi.org\/10.1097\/PGP.0000000000000263","journal-title":"Int J Gynecol Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-020-02759-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:15:13Z","timestamp":1611706513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-020-02759-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2759"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02759-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}